Intercept Pharmaceuticals Inc EV/EBIT
What is the EV/EBIT of Intercept Pharmaceuticals Inc?
The EV/EBIT of Intercept Pharmaceuticals Inc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Intercept Pharmaceuticals Inc
What does Intercept Pharmaceuticals Inc do?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Companies with ev/ebit similar to Intercept Pharmaceuticals Inc
- Country Club Hospitality & Holidays has EV/EBIT of N/A
- AF2 Capital has EV/EBIT of N/A
- Relmada Therapeutics Inc has EV/EBIT of N/A
- Emerge Commerce has EV/EBIT of N/A
- Bank of Marin Bancorp has EV/EBIT of N/A
- Vita 34 AG has EV/EBIT of N/A
- Intercept Pharmaceuticals Inc has EV/EBIT of N/A
- Raminfo has EV/EBIT of N/A
- Perceptron has EV/EBIT of N/A
- Suven Life Sciences has EV/EBIT of N/A
- Morarjee Textiles has EV/EBIT of N/A
- Crinetics Pharmaceuticals Inc has EV/EBIT of N/A
- Ramky Infrastructure has EV/EBIT of N/A